New distributor agreement between Atelerix (UK) and Scintila S.R.O (Czech Republic and Slovakia).

We are proud to announce the beginning of a new distribution agreement with Scintila S.R.O, who will be distributing our products across Czech Republic and Slovakia.

Our global customer base is growing rapidly due to problems associated with cryogenics, the vast increase in the use of complex physiologically relevant cell models in drug discovery, and our movement towards the regulated market of cell and gene therapy. Under this agreement, Scintila S.R.O, will increase our visibility and distribute Atelerix’s portfolio of hypothermic cell, tissue, and virus preservation technology.

Scintila, s.r.o. is a distribution company that has been focusing on long-term cooperation with top and renowned foreign manufacturers of products and technologies for biomedical research and diagnostics for almost 20 years.
 
They offer high-quality, innovative reagents and devices for research laboratories and clinical workplaces in the Czech Republic and Slovakia. With an important customer base consisting of key university hospitals, universities, academies of science and biotechnology companies.